Skip to main content

Open

Medical Student Education Program (MSE)

Request Ticket // Limit: 1 (COM-T) // Tickets Available: 1 

Limiting Language
You may not submit more than one application. If you submit more than one application, we will only accept the last on-time submission.


Purpose
The purpose of the Medical Student Education (MSE) Program is to provide support to public medical schools in states ranked in the top quartile for projected primary care provider shortages. to expand or enhance education for medical students preparing to become physicians. This expansion can include funding for direct student supports which help students be successful in medical school, as well as for infrastructure development, maintenance, equipment, and minor renovations or alterations. The program is designed to prepare and encourage medical students to choose residencies and careers in primary care and serve Tribal, rural and other areas with primary care provider shortages in those states after they complete their residency.

  • Increase the number of primary care physicians practicing in states with a projected primary care physician shortage, particularly in rural Tribal and other areas with primary care provider shortages.
Funding Type
External Deadline
9/1/2026

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.

Purpose
This Notice of Funding Opportunity (NOFO) invites applications for a Research Coordinating Center (RCC) to participate in a consortium of clinical centers that will test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifestyle therapies that may be imperative to ensure normal psychological and physical development and to potentially avoid lifelong dependence on AOMs. Investigators should also evaluate potential predictors of response/ nonresponse to various treatment strategies under evaluation. The clinical centers may conduct independent or multicenter trials but will collaborate on the development of protocols, use of common measures and data elements, use of a central laboratory and standardized procedures to collect data and biospecimens, and data analyses and manuscripts

The RCC will lead, manage, and harmonize efforts for the Consortium including 1) providing management and administrative support; 2) providing leadership and expertise on statistical design and analysis, 3) providing research coordination with a central laboratory, 4) harmonizing data collection methods and use of common data elements, 5) developing the database; 6) conducting data management and data analyses for Consortium studies; and 7) fostering research collaborations. This NOFO uses a cooperative agreement mechanism (U24) and runs in parallel with a companion NOFO (RFA-DK-27-121).

Full sponsor guidelines are linked here. 
 

Funding Type
External Deadline
10/9/2026
Solicitation Type

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.


Purpose
This Notice of Funding Opportunity (NOFO) invites applications from clinical centers to participate in a consortium to test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifestyle therapies that may be imperative to ensure normal psychological and physical development and to potentially avoid lifelong dependence on AOMs.  Investigators should also evaluate potential predictors of response/ nonresponse to various treatment strategies under evaluation. The clinical centers may conduct independent or multicenter trials but will collaborate on the development of protocols, use of common measures and data elements, use of a central laboratory and standardized procedures to collect data and biospecimens, and data analyses and manuscripts. 

Full sponsor guidelines are linked here. 

Funding Type
External Deadline
10/9/2026
Solicitation Type

Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique entity identifier (UEI) number or NIH IPF number) is allowed.

Purpose
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.

Full sponsor guidelines are linked here. 

Funding Type
External Deadline
9/24/2026
Solicitation Type

Pax Silica Artificial Intelligence Assistance Project

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Applicants can submit one application in response to the NOFO.  If more than one application is submitted by an organization, only the final application received, and time stamped by grants.gov will be reviewed for eligibility.  Each application can include multiple projects that will be evaluated independently.  

Priority Countries and Economies:
Australia, Costa Rica, Finland, Greece, India, Indonesia, Israel, Japan, Kazakhstan, Norway, Panama, Philippines, Qatar, Singapore, South Korea, Sweden, Taiwan, Turkiye, United Arab Emirates, United Kingdom, Vietnam

Executive Summary
Pax Silica is the Department’s flagship programmatic and policy initiative to strengthen global Artificial Intelligence (AI) supply chain security, advancing new economic security consensus among allies and trusted partners.  This U.S.-led initiative is working at speed to build a secure, resilient, innovation-driven technology ecosystem spanning critical minerals, energy, advanced manufacturing, semiconductors, AI infrastructure, and logistics.  The Pax Silica Fund, including funds appropriated to the Department of State under the International Technology Security and Innovation Fund, supports programming with partner economies that advances President Trump’s America’s AI Action Plan, Executive Order 14320 on Promoting the Export of the American AI Technology Stack, and 14179 on Removing Barriers to American Leadership in Artificial Intelligence. The Pax Fund does this by disrupting strategic competitors’ efforts to disrupt secure and reliable semiconductor supply chains and critical emerging technologies, including AI, biotechnologies, quantum, semiconductor, and space technologies. Specifically, the Pax Fund provides seed funding for innovative pilot projects to leverage international partnerships that reduce coercive dependencies, secure global technology supply chains, address AI supply chain opportunities and vulnerabilities, explore joint investment, protect sensitive technologies, and build trusted digital infrastructure. Through Pax Silica, the United States partners with the world’s most advanced economies in the strategic regions of the Indo-Pacific, Europe, the Middle East, and Latin America to outcompete strategic competitors for decades-long economic partnerships, generating multi-billion dollar deals for U.S. companies and creating thousands of American jobs with every success. Leveraging foreign assistance from the Pax Fund, this NOFO launches the Pax Silica Artificial Intelligence (AI) Assistance Project—a historic first-of-its-kind programmatic initiative to strengthen global AI supply chain security by creating a trusted supply chain credentialing and provenance platform to secure the AI supply chain in partner countries and economies. 

Funding Type
External Deadline
8/20/2026
Solicitation Type

Scholarships for Disadvantaged Students (SDS)

One per health profession degree program (see eligibility below)

J. Young (College of Nursing) - degree programs include bachelor's degree nursing students (BSN), master's entry program to nursing (MEPN), and doctor of nursing practice (DNP). 

M. Alt (College of Science), Speech, Language, and Hearing Sciences (SLHS) - Allied health, Graduate Degree in Speech pathology.

Limiting Language
You may submit more than one application under the same Unique Entity Identifier (UEI) if each proposes a distinct project. We will only review your last validated application for each distinct project before the deadline. 

You may not submit more than one application per health professions degree program. If you submit more than one application, we will only accept the last on-time submission. 

While multiple applications from an institution are allowed, only a maximum of three per institution may be funded. Collaborative proposals are not allowed.

Eligible Health Profession Degree Programs
Eligible health professions schools include the following: 

  1. Medicine (Doctor of allopathic medicine, Doctor of osteopathic medicine); 
  2. Dentistry (Doctor of dentistry); 
  3. Other health disciplines (Doctor of veterinary medicine, Doctor of optometry, Doctor of podiatry medicine, Doctor of pharmacy, Doctor of chiropractic medicine); 
  4. Behavioral and mental health (Graduate degree in clinical psychology; Graduate degree in clinical social work; Graduate degree in gerontological counseling; Graduate degree in marriage and family therapy; Graduate degree in mental health counseling; Graduate degree in rehabilitation counseling); 
  5. Public health (Graduate degree in health administration; Graduate degree in public health); 
  6. Allied health (Bachelor's and graduate degrees in dietetics; Graduate degree in audiology; Graduate degree in occupational therapy; Graduate degree in physical therapy; Graduate degree in speech pathology; Bachelor's and graduate degrees in dental hygiene; Bachelor's and graduate degrees in medical laboratory technology, Bachelor's degree in radiologic technology); 
  7. Nursing (Associate, bachelor's, and graduate degrees in nursing (pre-nursing is not eligible)); 
  8. Midwifery (Certified nursing and non-nursing graduate degrees in midwifery (pre-nursing or pre-midwifery is not eligible));
  9. Physician Assistant (Graduate degree in physician assistant studies).

Summary
The Scholarships for Disadvantaged Students (SDS) program increases the health professionsand nursing workforce by providing awards to eligible health professions schools for use in awarding scholarships to students from disadvantaged backgrounds who have a financial need.

Funding Type
External Deadline
7/28/2026

NIH Director's Early Independence Award (DP5 Clinical Trial Optional)

Request Ticket // Limit: 2 // Tickets Available: 2

Limiting Language 
Only two applications per institution (identified by Unique Entity Identifier (UEI) number or NIH IPF number) are allowed.


Program Description
Full sponsor guidelines are linked here.

The NIH Director's Early Independence Award helps talented new researchers begin their own independent research program soon after finishing their doctoral degree or clinical training, without first doing postdoctoral training.The award accepts applications on any topic fitting the NIH mission. It is part of the NIH Common Fund's High-Risk, High-Reward Research program.

Eligible Individuals (Program Director/Principal Investigator)
Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. 

Requirements

  • One PD/PI only: Applications can have only one PD/PI. Multiple PD/PIs are not allowed. Only the PD/PI may be listed as Senior/Key Personnel and submit a biosketch.
  • Citizenship: U.S. citizenship is not required. If the PD/PI is not a U.S. citizen, the institution must ensure the visa permit allows them to do the proposed research in the U.S. for the full project period.
  • Degree or clinical training dates: The PD/PI must complete their terminal doctoral degree or post-graduate clinical training between May 1, 2025, and September 30, 2027.
    • The date shown on the official transcript is considered the date the degree was completed.
    • Clinical training includes residency and fellowship.
    • At the time of award, either:
      • The PD/PI must have an eligible doctoral degree from an accredited U.S. or foreign institution, oR
      • An authorized official must confirm all degree requirements are complete and the degree will be awarded before September 30, 2027.
  • Post-doctoral experience: The PD/PI must not have more than 12 months of postdoctoral training after an earlier, non-terminal doctoral degree. This applies only to individuals with multiple doctoral degrees.
  • Effort required:
    • Years 1-2: At least 9.6 person-months per year (80% effort) on the award project
    • Years 3-5:  At least 9.6 person-months per year (80% effort) on independent research overall, including the award project and any other independent research led by the PD/PI.
  • Non-independence required: At the time of application, the PD/PI must still be non-independent. All the following must apply:
    • Research direction requires mentor approval
    • Research is mainly supported through another investigator's funding (mentored fellowships, such as an NIH F31/F32 or NSF Graduate Research Fellowship, do not make an applicant ineligible)
    • No institutionally assigned research space
    • Cannot apply for an NIH R01 without a special institutional waiver or exception

The PD/PI may become independent before the award starts and still remain eligible.

  • Independent position required: The PD/PI must have a guaranteed, pending independent research position and be able to begin independent research by the project start date.
    • The position does not have to be permanent or tenure-track.
    • The position may depend on receiving this award.
    • The institution must provide substantial support, as described in the application.
    • Moving to a new institution may be advantageous but is not required.
  • Career awards: ThePD/PI may apply for both a K award and DP5 simultaneously, but the projects must not overlap scientifically. A PD/PI cannot hold both simultaneously; if awarded the DP5, the K award must be relinquished.
  • Site visit: NIH will conduct a site visit near the end of the first year to assess progress and confirm institutional support and independence. If support is insufficient, NIH may take corrective action, including reducing or terminating funding.
Funding Type
External Deadline
9/10/2026
Internal Deadline
Solicitation Type

The 2027 YSEALI Regional Workshop: Securing Supply Chains: Market Opportunities in the Fourth Industrial Revolution

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Applicants are only allowed to submit one proposal per organization. If more than one proposal is submitted from an organization, all proposals from that institution will be considered ineligible for funding under this funding opportunity.

Executive Summary
The U.S. Department of State’s Consulate General Ho Chi Minh City, Vietnam and U.S. Consulate General Surabaya, Indonesia announces an open competition to implement a program to organizations.

In 2024, trade in goods and services between the United States and ASEAN reached almost $572 billion, supporting over 625,000 American jobs. As a hub for some of the world’s most important manufacturers and shipping routes, Southeast Asia depends on secure, resilient, and diversified supply chains grounded in fair and reciprocal trade practices. President Trump’s America First foreign policy prioritizes secure supply chains that strengthen U.S. economic and national security while advancing cooperation with allies and partners. This is especially important in the critical minerals sector, where the United States is working with regional partners to diversify supply chains in alignment with Executive Order 14154, “Unleashing American Energy.” 

Against this backdrop, the Young Southeast Asian Leaders Initiative (YSEALI) will host a regional workshop titled Securing Supply Chains: Market Opportunities in the Fourth Industrial Revolution. U.S. Consulate General Ho Chi Minh City and U.S. Consulate General Surabaya seek proposals to design and implement a four-day workshop in Vietnam and Indonesia for up to 55 ASEAN leaders ages 22–35 occurring in May 2027. Vietnam and Indonesia represent two of the most promising markets for increased commercial cooperation with the United States and bring complementary expertise in critical minerals (Indonesia) and in integrated and resilient supply chains (Vietnam). 

Participants will examine supply chain resilience, critical minerals, and emerging technologies such as blockchain and AI through case studies, interactive exercises, and collaborative problem- solving. The program will equip early-stage professionals with practical skills to strengthen regional supply chains, support informed investment decisions, and advance U.S. and Southeast Asian prosperity and security.

Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language 
Under this NOFO, you may submit only one application under your organization’s Unique Entity Identifier (UEI).

Summary 
The purpose of this Notice of Funding Opportunity (NOFO) is to decrease the impact of specific parasitic infections in the U.S. with public health practices and disease control strategies. The NOFO focuses on three parasitic infection areas: 
• Chagas disease.
• Soil-transmitted helminths. 
• Other parasitic diseases of domestic concern in the U.S. 

This NOFO will continue CDC’s Parasitic Disease Branch work to help healthcare providers (HCPs) better understand, detect, treat, and prevent parasitic infections. Improved understanding and management of parasitic diseases in the U.S. will help make Americans stronger, safer, and more prosperous. There are three components of this NOFO. You may apply for only one: 
• Component A will improve HCPs’ knowledge and practices. Increase testing and management of people with or at risk of Chagas disease. Expand the use of best practices, training tools, and materials. 
• Component B will strengthen public health efforts to monitor and control soil-transmitted helminth infections (like hookworm). It focuses on areas in the Southeastern U.S. (as defined by the U.S. Census Bureau) that are historically affected. 
• Component C will target the prevention, control, health education, and, where applicable, elimination of other parasitic diseases in the U.S. Diseases include cyclosporiasis, cysticercosis, echinococcosis, leishmaniasis, lymphatic filariasis, and toxoplasmosis.

We will not accept proposals focused on malaria, amoebiasis,cryptosporidiosis, giardiasis, or any international activities. Your strategies should aim for significant public health benefits and reach a large portion of at-risk populations.

Funding Type
External Deadline
7/17/2026

Combating Transnational Criminal Organizations through Data-Driven Analysis and Customized Investigative Mentoring

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Langauge
Applicants are only allowed to submit one proposal per organization. If more than one proposal is submitted from an organization, all proposals from that institution will be considered ineligible for funding. Organizations may form a consortium and submit a combined proposal; however, one organization should be designated as the lead applicant and other organization(s) listed as sub-recipient partner(s).

Description
This project will fully support a newly established analytical center within the Bosnia and Herzegovina State Prosecutors Office that can provide a data-driven analysis and tailored investigative mentoring to combat TCOs that threaten U.S. security through illicit finance, corruption, narcotics trafficking, and other cross-border criminal activity.

Research Category
Funding Type
External Deadline
8/17/2026
Solicitation Type